What is Stifel's price target for DCPH?

Stifel's latest stated price target for Deciphera Pharmaceuticals Inc. (DCPH) is $20, from its action on Aug 10, 2023.

What is Stifel's rating on DCPH?

Stifel rates DCPH Buy, a bullish rating, as of Aug 10, 2023.

When did Stifel last change its view on DCPH?

On Aug 10, 2023, Stifel upgrades to Buy from Hold, price target $14 to $20.

Stifel DCPH price target and rating history

Deciphera Pharmaceuticals Inc. (DCPH) · Health Care

Stifel rates Deciphera Pharmaceuticals Inc. (DCPH) Buy with a $20 price target, as of its latest action on Aug 10, 2023. It has published 4 rating actions on DCPH since September 2021, including 1 upgrade and 2 downgrades.

Current rating: Buy
Price target: $20
Median target, all firms: Too few
Actions on DCPH: 4

Stifel price target on DCPH

Stifel price target on DCPH, each point a stated target, September 2021 to August 2023.

Every Stifel rating on DCPH

Aug 10, 2023
UpgradeStifel upgrades to Buy from Hold, price target $14 to $20
Nov 8, 2021
DowngradeStifel downgrades to Hold from Buy, price target $60 to $10
Nov 8, 2021
DowngradeStifel downgrades to Hold from Buy
Sep 30, 2021
ResumeStifel resumes coverage at Buy, price target $60

Questions about Stifel and DCPH

What is Stifel's price target for DCPH?: Stifel's latest stated price target for Deciphera Pharmaceuticals Inc. (DCPH) is $20, from its action on Aug 10, 2023.
What is Stifel's rating on DCPH?: Stifel rates DCPH Buy, a bullish rating, as of Aug 10, 2023.
When did Stifel last change its view on DCPH?: On Aug 10, 2023, Stifel upgrades to Buy from Hold, price target $14 to $20.

More DCPH rating histories

H.C. Wainwright3

All Stifel ratings DCPH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.